Renascience Inc.

¥774.00As of Sun 8 Nov 2026, 12:00 UTC
TSE:4889Healthcare
Country Japan
PE (Fwd) •••
TSR 5Y CAGR (0.98%)
Div yield —
ROE (12.96%)
Medical (Pharmaceuticals)
Beta (5Y) 1.83
PE TTM —
TSR TTM (59.20%)
Mkt cap ¥10.66B
ROIC (8.61%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥923
19.29%
74.06%
Hold 0|6|7|8|4
3Q26
4Q26
1Q27
2Q27
Earnings per share¥
10.13
11.33
12.58
13.25
10.06%
16.96%
18.65%
31.52%
Revenue¥B
1.187
1.176
1.187
1.179
3.89%
1.19%
4.56%
4.04%
Peers (US$67.70M)
Cap (US$)
PE
84.01M
17.67x
65.44M
35.24x
Capital
TTM
5Y
10Y
Leveragex
1.006
0.588
0.439
EBIT/Intx
1.890
0.830
0.721
Own earn%
(20.59)
94.98
108.99
Sh yield%
49.63
15.84
17.53
Owners
Insiders/Inst%
1.60
71.51
Short interest%
2.57
SBC / revenue%
0.22
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
3
Op margin range%
25–29
$1 testx
−0.2
Incr. ROIC%
9